Human immunodeficiency virus infection and cerebral malaria in children in Uganda: A case-control study

BMC Pediatrics

Volumn 11, Issue , 2011, Pages

  Imani, Peace D ^a   Musoke, Philippa ^a   Byarugaba, Justus ^a   Tumwine, James K ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; INSECTICIDE; ANTIMALARIAL AGENT;

ARTICLE; BED NET; BRAIN MALARIA; CASE CONTROL STUDY; CHILD; CHILDHOOD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PROPHYLAXIS; RISK FACTOR; SCHOOL CHILD; UGANDA; ANEMIA; CD4 LYMPHOCYTE COUNT; DISEASE PREDISPOSITION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOCOMPROMISED PATIENT; INFANT; MALARIA; PARASITEMIA; PARASITOLOGY;

ANEMIA; ANTIMALARIALS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALARIA, CEREBRAL; MALE; PARASITEMIA; RISK FACTORS; UGANDA;

EID: 78651365813     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-11-5     Document Type: Article

References (35)

1. Abu-Raddad L, Patnaik P, Kublin J. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006, 314(5805):1603-6. 10.1126/science.1132338, 17158329.
2. Chirenda J, Siziya S, Tshimanga M. Association of HIV infection with the development of severe and complicated malaria cases at a rural hospital in Zimbabwe. Cent Afr J Med 2000, 46(1):5-9.
3. Kamya M, Gasasira A, Yeka A, Bakyaita N, Nsobya S, Francis D, et al. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis 2006, 193(1):9-15. 10.1086/498577, 16323126.
4. Cohen C, Karstaedt A, Frean J, Thomas J, Govender N, Prentice E, et al. Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis 2005, 41(11):1631-7. 10.1086/498023, 16267737.
5. Patnaik P, Jere CS, Miller WC, Hoffman IF, Wirima J, Pendame R, et al. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J Infect Dis 2005, 192(6):984-91. 10.1086/432730, 16107950.
6. Hewitt K, Steketee R, Mwapasa V, Whitworth J, French N. Interactions between HIV and malaria in non-pregnant adults: evidence and implications. AIDS 2006, 20(16):1993-2004. 10.1097/01.aids.0000247572.95880.92, 17053345.
7. Chirenda J, Murugasampillay S. Malaria and HIV co-infection: available evidence, gaps and possible interventions. Cent Afr J Med 2003, 49(5-6):66-71.
8. Chalwe V, Van geertruyden J, Mukwamataba D, Menten J, Kamalamba J, Mulenga M, et al. Increased risk for severe malaria in HIV-1-infected adults, Zambia. Emerg Infect Dis 2009, 15(5):749. quiz 858, 10.3201/eid1505.081009, 2687012, 19402961.
9. Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, Gilks CF. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. Aids 2004, 18(3):547-54. 10.1097/00002030-200402200-00023, 15090809.
10. Chaisavaneeyakorn S, Moore J, Otieno J, Chaiyaroj S, Perkins D, Shi Y, et al. Immunity to placental malaria. III. Impairment of interleukin(IL)-12, not IL-18, and interferon-inducible protein-10 responses in the placental intervillous blood of human immunodeficiency virus/malaria-coinfected women. J Infect Dis 2002, 185(1):127-31. 10.1086/338013, 11756993.
11. N'Gom P, Jaffar S, Ricard D, Wilkins A, Ariyoshi K, Morgan G, et al. Immune stimulation by syphilis and malaria in HIV-2-infected and uninfected villagers in West Africa. Br J Biomed Sci 1997, 54(4):251-5.
12. Migot F, Ouedraogo J, Diallo J, Zampan H, Dubois B, Scott-Finnigan T, et al. Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso. Parasite Immunol 1996, 18(7):333-9. 10.1046/j.1365-3024.1996.d01-116.x, 9229386.
13. Van Geertruyden J, Van Eijk E, Yosaatmadja F, Kasongo W, Mulenga M, D'Alessandro U, et al. The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia. Malar J 2009, 8:258. 10.1186/1475-2875-8-258, 2784793, 19922664.
14. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004, 364(9443):1428-34. 10.1016/S0140-6736(04)17225-5, 15488218.
15. Greenberg A, Nsa W, Ryder R, Medi M, Nzeza M, Kitadi N, et al. Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children. N Engl J Med 1991, 325(2):105-9. 10.1056/NEJM199107113250206, 2052043.
16. Angyo I, Pam S, Szlachetka R. Clinical pattern and outcome in children with acute severe falciparum malaria at Jos University Teaching Hospital, Nigeria. East Afr Med J 1996, 73(12):823-6.
17. Ndeezi G. Clinical trial to compare the efficacy of intramuscular Chloroquine with intramuscular Quinine in the treatment of cerebral malaria in children. 1992, Kampala: Makerere University.
18. Idro R, Karamagi C, Tumwine J. Immediate outcome and prognostic factors for cerebral malaria among children admitted to Mulago Hospital, Uganda. Ann Trop Paediatr 2004, 24(1):17-24. 10.1179/027249304225013240, 15005962.
19. Aceng J, Byarugaba J, Tumwine J. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial. BMJ 2005, 330(7487):334. 10.1136/bmj.330.7487.334, 548725, 15705690.
20. Guidelines for treatment of malaria. 2010, World Health Organization.
21. Fleiss. Statistical Methods for Rates and Proportions. 1981, 38-45. Wiley, 2.
22. Antiretroviral treatment of HIV infection in infants and children in resource-limited settings, towards universal access. 2005, World Health Organization.
23. Basic Laboratory Methods in Medical Parasitology. 1991, World Health Organization.
24. Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, Gilks CF. Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr Infect Dis J 2003, 22(12):1057-63. 10.1097/01.inf.0000101188.95433.60, 14688565.
25. Berkley J, Bejon P, Mwangi T, Gwer S, Maitland K, Williams T, et al. HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis 2009, 49(3):336-43. 10.1086/600299, 2853703, 19548833.
26. Gasasira A, editor. Use of both cotrimoxazole and insecticide-treated bednets dramatically lowers the risk of malaria in HIV-positive children. Fourteenth Conference on Retroviruses and Opportunistic Infections 2007, Los Angeles.
27. Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 2006, 367(9518):1256-61. 10.1016/S0140-6736(06)68541-3, 16631881.
28. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000, 356(9235):1051-6. 10.1016/S0140-6736(00)02727-6, 11009139.
29. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. Aids 2001, 15(7):899-906. 10.1097/00002030-200105040-00010, 11399962.
30. Mannick JB, Stamler JS, Teng E, Simpson N, Lawrence J, Jordan J, et al. Nitric oxide modulates HIV-1 replication. J Acquir Immune Defic Syndr 1999, 22(1):1-9.
31. Maneerat Y, Viriyavejakul P, Punpoowong B, Jones M, Wilairatana P, Pongponratn E, et al. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology 2000, 37(3):269-77. 10.1046/j.1365-2559.2000.00989.x, 10971704.
32. Niyongabo T, Deloron P, Aubry P, Ndarugirire F, Manirakiza F, Muhirwa G, et al. Prognostic indicators in adult cerebral malaria: a study in Burundi, an area of high prevalence of HIV infection. Acta Trop 1994, 56(4):299-305. 10.1016/0001-706X(94)90101-5, 8023753.
33. Laufer M, van Oosterhout J, Thesing P, Thumba F, Zijlstra E, Graham S, et al. Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi. J Infect Dis 2006, 193(6):872-8. 10.1086/500245, 16479522.
34. Satpathy S, Mohanty N, Nanda P, Samal G. Severe falciparum malaria. Indian J Pediatr 2004, 71(2):133-5. 10.1007/BF02723094, 15053376.
35. Safeukui-Noubissi I, Ranque S, Poudiougou B, Keita M, Traoré A, Traoré D, et al. Risk factors for severe malaria in Bamako, Mali: a matched case-control study. Microbes Infect 2004, 6(6):572-8. 10.1016/j.micinf.2004.02.007, 15158191.